Weighing the benefits and downsides of prostate-specific antigen screening.
Michael
M
Pignone
D000367:Age Factors; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D017410:Practice Guidelines as Topic; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis* / Q000401:mortality; D018570:Risk Assessment
D017430:Prostate-Specific Antigen